FLORA GREEN: Open Payments
NPI 1982057345 · JACKSON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$480 in 7 payments from 7 companies in 2025. Trend: 2023 $1,005 · 2024 $757 · 2025 $480
Food & beverage: $480
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 1 | $124 |
| AstraZeneca Pharmaceuticals LP | 1 | $99 |
| Medtronic, Inc. | 1 | $93 |
| Otsuka America Pharmaceutical, Inc. | 1 | $85 |
| Insmed, Inc. | 1 | $47 |
| Abbott Laboratories | 1 | $17 |
| Novo Nordisk Inc | 1 | $15 |
Products named: BREZTRI, INTELLIS ADAPTIVESTIM, REXULTI, Arikayce, FREESTYLE LIBRE 3, Rybelsus.
Industry payments across MS — which companies pay providers there.
